| P2093 | author name string | Yves Le Vern | |
| | Denis Rasschaert | |
| | Ginette Dambrine | |
| | Sylvie Laurent | |
| | Souheila Amor | |
| | Sylvie Remy | |
| P2860 | cites work | Two cell lines from lymphomas of Marek's disease | Q69366456 |
| | Alternatively spliced variant deleting exons 7 and 8 of the human telomerase reverse transcriptase gene is dominantly expressed in the uterus | Q74411792 |
| | Alternative splicing and nonsense-mediated mRNA decay regulate gene expression of serum response factor | Q80608304 |
| | Vaccination against Marek's disease reduces telomerase activity and viral gene transcription in peripheral blood leukocytes from challenged chickens | Q81743463 |
| | Human telomerase and its regulation | Q24533247 |
| | Different levels of alternative splicing among eukaryotes | Q24670390 |
| | Specific Association of Human Telomerase Activity with Immortal Cells and Cancer | Q27860801 |
| | Comparative functional study of the viral telomerase RNA based on natural mutations | Q28243648 |
| | On the road to immortality: hTERT upregulation in cancer cells | Q28257238 |
| | The RNA component of human telomerase | Q28288330 |
| | Identification of a specific telomere terminal transferase activity in Tetrahymena extracts | Q28306745 |
| | Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans | Q29615184 |
| | Characterization of novel alternative splicing sites in human telomerase reverse transcriptase (hTERT): analysis of expression and mutual correlation in mRNA isoforms from normal and tumour tissues | Q33255709 |
| | Marek's disease virus: from miasma to model | Q33994187 |
| | Insights into the connection between cancer and alternative splicing | Q34008519 |
| | Mechanism of telomerase activation by v-Rel and its contribution to transformation | Q34233162 |
| | SC35 autoregulates its expression by promoting splicing events that destabilize its mRNAs | Q34583829 |
| | The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity | Q34785876 |
| | Telomerase: regulation, function and transformation | Q36103259 |
| | The splicing machinery is a genetic modifier of disease severity | Q36204731 |
| | Isolation of a candidate human telomerase catalytic subunit gene, which reveals complex splicing patterns in different cell types. | Q36885740 |
| | Pre-mRNA splicing aberrations and cancer. | Q36992038 |
| | Regulation of telomerase and telomeres: human tumor viruses take control | Q37053343 |
| | The coupling of alternative splicing and nonsense-mediated mRNA decay. | Q37124835 |
| | Recognition and elimination of nonsense mRNA. | Q37227734 |
| | The mammalian nonsense-mediated mRNA decay pathway: to decay or not to decay! Which players make the decision? | Q37375181 |
| | Structure-function relationships in telomerase genes. | Q37472153 |
| | Marek's disease is a natural model for lymphomas overexpressing Hodgkin's disease antigen (CD30) | Q37535521 |
| | Involvement of the oncoprotein c-Myc in viral telomerase RNA gene regulation during Marek's disease virus-induced lymphomagenesis | Q38304448 |
| | Complicated RNA splicing of chicken telomerase reverse transcriptase revealed by profiling cells both positive and negative for telomerase activity | Q38311950 |
| | Quantitation of telomerase components and hTERT mRNA splicing patterns in immortal human cells | Q39511317 |
| | The RNA subunit of telomerase is encoded by Marek's disease virus | Q39748978 |
| | Regulation of H-ras splice variant expression by cross talk between the p53 and nonsense-mediated mRNA decay pathways. | Q40091384 |
| | Human normal T lymphocytes and lymphoid cell lines do express alternative splicing variants of human telomerase reverse transcriptase (hTERT) mRNA. | Q40186605 |
| | Differential expression of full-length telomerase reverse transcriptase mRNA and telomerase activity between normal and malignant renal tissues | Q40408840 |
| | Induction of telomerase activity in avian lymphoblastoid cell line transformed by Marek's disease virus, MDCC-MSB1. | Q40539496 |
| | An alternate splicing variant of the human telomerase catalytic subunit inhibits telomerase activity | Q40825989 |
| | Changes in telomerase activity and telomere length during human T lymphocyte senescence | Q41120744 |
| | Quantification of hTERT splice variants in melanoma by SYBR green real-time polymerase chain reaction indicates a negative regulatory role for the beta deletion variant. | Q42203404 |
| | Cell lines derived from avian lymphomas exhibit two distinct phenotypes | Q42819170 |
| | Extensive coupling of alternative splicing of pre-mRNAs of serine/arginine (SR) genes with nonsense-mediated decay | Q43253390 |
| | Nitric oxide inhibits Marek's disease virus replication but is not the single decisive factor in interferon-gamma-mediated viral inhibition. | Q45739904 |
| | Establishment and characterization of a chicken hepatocellular carcinoma cell line, LMH. | Q52832723 |
| | Nonsense-mediated mRNA decay: target genes and functional diversification of effectors | Q57279018 |
| | Specific inhibition of nonsense-mediated mRNA decay components, SMG-1 or Upf1, rescues the phenotype of ullrich disease fibroblasts | Q58323613 |
| | Possible Regulation of Telomerase Activity by Transcription and Alternative Splicing of Telomerase Reverse Transcriptase in Human Melanoma | Q60589822 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | enzymologic gene expression regulation | Q70688407 |
| | alternative mRNA splicing, via spliceosome | Q21114084 |
| | neoplastic gene expression regulation | Q66660300 |
| P304 | page(s) | 571 | |
| P577 | publication date | 2010-10-21 | |
| P1433 | published in | BMC Cancer | Q326300 |
| P1476 | title | Alternative splicing and nonsense-mediated decay regulate telomerase reverse transcriptase (TERT) expression during virus-induced lymphomagenesis in vivo | |
| P478 | volume | 10 | |